SCHEMBL932267

SCHEMBL932267

CC1=NC(c2cccc(NC(=O)c3cnccn3)c2)(c2cc(C)c(OC(F)F)c(C)c2)N=C1N

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
RAB9A P51151 6/20 0.45
NPC1 O15118 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 1/20 0.44
BACE1 P56817 8/20 0.43
BACE2 Q9Y5Z0 1/20 0.43
GRM4 Q14833 1/20 0.42
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
BRAF P15056 1/20 0.40
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
KMT2A Q03164 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL931151 0.74 BACE1 (0.51) RAB9ANPC1SMN1; SMN2HPGDBACE1
SCHEMBL932083 0.74 BACE1 (0.50) BACE1BACE2KCNH2
SCHEMBL932175 0.73 BACE1 (0.51) BACE1BACE2KCNH2
SCHEMBL931679 0.73 BACE1 (0.77) BACE1BACE2KCNH2
SCHEMBL932089 0.71 BACE1 (0.62) BACE1BACE2KCNH2
SCHEMBL932392 0.68 BACE1 (0.65) BACE1BACE2KCNH2
SCHEMBL259290 0.67 RAB9A (0.69) GAARAB9ANPC1SMN1; SMN2HPGD
SCHEMBL10154865 0.67 BACE1 (0.80) BACE1
SCHEMBL1173084 0.66 BACE1 (0.80) BACE1
Hydrochloric Acid SCHEMBL1173268 0.66 BACE1 (0.79) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO claimed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed